24 July 2020 : Database Analysis
Prognostic Value of Enolase Gene Family in Colon Cancer
Xiaohang Pan1AC, Huawen Wu1BF, Guofu Chen1EF, Wenhuan Li1AD*DOI: 10.12659/MSM.922980
Med Sci Monit 2020; 26:e922980
Table 5 Pharmacological targets and drug for ENO3.
| Drug | PubChem CID | Mean | Enrichment | P-value |
|---|---|---|---|---|
| Tetracycline | 54675776 | −0.4 | −0.868 | 0.00008 |
| Trimethobenzamide | 5577 | −0.432 | −0.832 | 0.00032 |
| Cephaeline | 442195 | −0.654 | −0.794 | 0.00074 |
| Rilmenidine | 68712 | −0.225 | −0.851 | 0.00092 |
| 0317956-0000 | N/A* | −0.311 | −0.561 | 0.00646 |
| Levobunolol | 39468 | −0.277 | −0.763 | 0.00656 |
| Cefamandole | 456255 | −0.314 | −0.73 | 0.0107 |
| Diethylstilbestrol | 448537 | −0.323 | −0.61 | 0.01154 |
| Indoprofen | 3718 | −0.412 | −0.685 | 0.02152 |
| Quipazine | 5011 | −0.321 | −0.668 | 0.02733 |
| Tiaprofenic acid | 5468 | −0.271 | −0.642 | 0.03957 |
| Terazosin | 5401 | −0.313 | −0.637 | 0.04176 |
| N/A – not applicable. * Could not found CID in PubChem database. | ||||